{"id":"W4402468317","doi":"10.1016/j.ejca.2024.114327","title":"Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial","year":2024,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pembrolizumab; Medicine; Placebo; Adjuvant; Melanoma; Oncology; Stage (stratigraphy); Internal medicine; Adjuvant therapy; Surgery; Immunotherapy; Cancer; Pathology; Cancer research; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001461187,0.0001239185,0.0004413256,0.0008395062,0.00001891966,0.00003484611,0.0001793789,0.0000223786,0.0007595465],"category_scores_gemma":[0.00008490831,0.00008267615,0.0002850344,0.0009580073,0.00003742063,0.00005899828,0.00003516255,0.000402887,0.00001252854],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000192455,"about_ca_system_score_gemma":0.0001402143,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008697051,"about_ca_topic_score_gemma":0.0004767404,"domain_scores_codex":[0.9981205,0.0003820268,0.0006926744,0.0001529692,0.0004837742,0.0001680506],"domain_scores_gemma":[0.9993036,0.0001309079,0.0002246661,0.0002069548,0.00006691069,0.00006692702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.6980626,0.001011672,0.004870521,0.0004956024,0.01008079,0.03960958,0.02218837,0.01604411,0.002271858,0.001196592,0.01411525,0.1900531],"study_design_scores_gemma":[0.2941115,0.009240675,0.1033133,0.001357818,0.007918514,0.000396042,0.01051979,0.006153521,0.0005908508,0.00002039999,0.5657739,0.0006037407],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9723182,0.001952428,0.0001183586,0.0009943752,0.001296437,0.0003205969,0.00001083544,0.00001168725,0.02297712],"genre_scores_gemma":[0.9963838,0.0004870202,0.00003278503,0.0001243605,0.0004036757,0.000003427146,0.0000022388,0.00002146466,0.002541163],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5516586,"threshold_uncertainty_score":0.8316502,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02552894185840873,"score_gpt":0.3106194375100184,"score_spread":0.2850904956516097,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}